Successful Treatment of Henoch-Schönlein Purpura-associated Hematochezia in a Child with Hemophilia A: a Case Report
Overview
Authors
Affiliations
Background: Henoch-Schönlein purpura (HSP) is a common form of immunological vasculitis in children. Hemophilia A is a genetic disorder and characterized by spontaneous hemorrhage or prolonged bleeding due to factor VIII deficiency. Both diseases increase the risk of bleeding, but they have different mechanisms. How should we treat patients with both diseases?
Case Presentation: An 8-year-old male with hemophilia A was diagnosed with HSP while receiving coagulation factor VIII replacement therapy in our hospital. Hematochezia occurred 6 days after the diagnosis of HSP. And he treated with coagulation FVIII, methylprednisolone and hemostatic drugs.
Conclusions: There is no causal relationship between hemophilia A and HSP, but both diseases can cause bleeding. This child's hematochezia was caused by HSP, but hemophilia could not be ignored during the treatment. Our case report adds to the present body of knowledge about the treatment of HSP associated hematochezia in a child with hemophilia A.
A rare twist: COVID-19 infection masquerading as IgA vasculitis in a hemophilia a patient.
Alnaqbi K, Abunamous N, Saleem T Clin Rheumatol. 2024; 43(4):1393-1399.
PMID: 38353792 DOI: 10.1007/s10067-024-06902-x.